Theranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group.
The San Diego-based startup leverages lab-on-a-chip technology it says can run through up to 128 different tests on a single finger prick of blood in. view full post
Tuesday, 22 November 2016
Genalyte raises $36 million from Khosla for its one-drop blood test
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment